RowDiagnosed 2026-10-21 22:28:36 KSTEELVNAI Stock Diagnostic ReportEnliven Therapeutics CMO Collins sells $192,342 in ELVN stockThe news that Enliven Therapeutics' Chief Medical Officer sold approximately $13,000 worth of ELVN stock is assessed as a neutral internal transaction with limited impact.View Source Article ↗ AI CATALYST SCORE30 / 100Score computed by Sentinel V12REFERENCE PRICENot measuredReference entry price at analysis time 👍 0🔥 0🤔 0🔗 0𝕏f🔗📤